Lite Strategy (LITS) Revenue (2016 - 2023)
Lite Strategy (LITS) posted quarterly Revenue of $65.3 million for Q3 2023, up 647.96% year-over-year from $8.7 million in Q3 2022, and up 4381.61% quarter-over-quarter from $1.5 million in Q2 2023.
Lite Strategy (LITS) Revenue (2016 - 2023) Analysis & Trends
Lite Strategy's Revenue history runs 8 years deep, the most recent figure standing at $65.3 million for Q3 2023.
- In Q3 2023, Revenue rose 647.96% year-over-year to $65.3 million; the TTM figure through Jun 2024 stood at $65.3 million (up 33.76% YoY), while the FY2024 annual figure was $65.3 million, up 33.76% from the prior year.
- Revenue for Q3 2023 stood at $65.3 million, up from $1.5 million in the prior quarter.
- The five-year high for Revenue was $65.3 million in Q3 2023, with the low at $1.0 million in Q4 2019.
- The 5-year median for Revenue is $7.8 million (2021), against an average of $11.6 million.
- The sharpest annual moves came in 2020 and 2023: Revenue jumped 2158.99% in 2020, then plunged 87.23% in 2023.
- Lite Strategy's Revenue stood at $1.0 million in 2019, then jumped by 1149.5% to $12.6 million in 2020, then dropped by 6.06% to $11.8 million in 2021, then jumped by 176.66% to $32.7 million in 2022, then surged by 99.47% to $65.3 million in 2023.
- Business Quant data shows LITS's Revenue at $65.3 million in Q3 2023, $1.5 million in Q2 2023, and $5.9 million in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Lite Strategy | 33.69 Mn | 26.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 65.30 Mn |
| Jun 30, 2023 | 1.46 Mn |
| Mar 31, 2023 | 5.89 Mn |
| Dec 31, 2022 | 32.74 Mn |
| Sep 30, 2022 | 8.73 Mn |
| Jun 30, 2022 | 11.41 Mn |
| Mar 31, 2022 | 9.69 Mn |
| Dec 31, 2021 | 11.83 Mn |
| Sep 30, 2021 | 7.76 Mn |
| Jun 30, 2021 | 7.45 Mn |
| Mar 31, 2021 | 8.11 Mn |
| Dec 31, 2020 | 12.60 Mn |
| Sep 30, 2020 | 6.64 Mn |
| Jun 30, 2020 | 25.50 Mn |
| Mar 31, 2020 | 1.24 Mn |
| Dec 31, 2019 | 1.01 Mn |
| Sep 30, 2019 | 1.16 Mn |
| Jun 30, 2019 | 1.13 Mn |
| Mar 31, 2019 | 1.25 Mn |
| Dec 31, 2018 | 2.05 Mn |